Skip to main content

Table 2 Frequency of BST-2 Polymorphism in HIV-1 subtype C chronically infected cohort and uninfected cohorts of black South Africans

From: Bone marrow stromal antigen 2 (BST-2) genetic variants influence expression levels and disease outcome in HIV-1 chronically infected patients

SNP   Study population HI vs HU
HIV infected (HI) HIV uninfected (HU) OR [95% CI] p-value
MAF   n = 123 (%) n = 20 (%)   
rs919266 A 3 (1.2) 2 (5.0) N/A N/A
rs919267 T 95 (38.6) 14 (65.0) 0.29 [10.30–9.72] < 0.0001
rs9576 A 25 (11.0) 4 (10.0) N/A N/A
rs919266 G/G 120 (97.6) 18 (90.0)   
G/A 3 (2.4) 2 (10.0)   
AA 0 (0.0) 0 (0.0)  
rs919267 C/C 51 (41.5) 3 (15.0)   
C/T 49 (39.8) 8 (40.0)   
TT 23 (18.7) 9 (45.0)   
rs9576 C/C 97 (79.5) 16 (80.0)   
C/A 25 (20.5) 4 (20.0)   
AA 0 (0.0) 0 (0.0)